Article
Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
The Canadian journal of cardiology - 1 Jan 2000
Austin Stephanie E A, Hegele Robert A
Abstract excerpt
Direct-to-consumer (DTC) genetic testing for cardiovascular disease (CVD) is becoming increasingly accessible due to technological advances, falling prices, and assertive marketing. However, information to guide physicians and patients on how to interpret or react clinically to DTC genetic test results is scarce. We report the case of a 52-year-old man with a family history of CVD who had DTC genetic testing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
